DNA topoisomerases from rat liver: physiological variations.
about
Inhibitory effects of quinolone antibacterial agents on eucaryotic topoisomerases and related test systemsEffect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblastsInhibition of topoisomerase I by antibodies in sera from scleroderma patientsDifferential expression of DNA topoisomerases I and II during the eukaryotic cell cycle.Heparin and liver heparan sulfate can rescue hepatoma cells from topotecan action.Topoisomerase II is a structural component of mitotic chromosome scaffolds.Abundance of nuclear DNA topoisomerase II is correlated with proliferation in Arabidopsis thaliana.Reduced DNA topoisomerase II activity in ataxia-telangiectasia cells.A consensus sequence for cleavage by vertebrate DNA topoisomerase II.Reverse gyrase, a hallmark of the hyperthermophilic archaebacteria.Regulation of DNA repair in serum-stimulated xeroderma pigmentosum cells.Topoisomerase II: A specific marker for cell proliferation.Mitotic chromatin condensation in vitro using somatic cell extracts and nuclei with variable levels of endogenous topoisomerase II.Human cytomegalovirus induces expression of cellular topoisomerase II.DNase I hypersensitivity is independent of endogenous topoisomerase II activity during chicken erythrocyte differentiationTopoisomerase-specific drug sensitivity in relation to cell cycle progression.Immunohistochemical detection of DNA topoisomerase I in formalin fixed, paraffin wax embedded normal tissues and in ovarian carcinomas.ATP-independent type II topoisomerase from trypanosomes.Phosphorylation of DNA topoisomerase II by casein kinase II: modulation of eukaryotic topoisomerase II activity in vitroIn vitro assays used to measure the activity of topoisomerases.Emerging paradigms in cardiomyopathies associated with cancer therapies.Biochemical characteristics and physiological significance of major DNA topoisomerases.Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus.Aryl-fluoroquinolone derivatives A-56619 (difloxacin) and A-56620 inhibit mitogen-induced human mononuclear cell proliferation.The helical repeat of DNA at high temperature.Heterogeneity of mammalian DNA ligase detected on activity and DNA sequencing gels.Purification and enzymological characterization of DNA-dependent ATPase IV from the Novikoff hepatomaThe role of DNA topoisomerases II in drug resistance.DNA topoisomerase II activity in nonreplicating, transcriptionally inactive, chicken late spermatids.Reverse gyrase binding to DNA alters the double helix structure and produces single-strand cleavage in the absence of ATP.High positive supercoiling in vitro catalyzed by an ATP and polyethylene glycol-stimulated topoisomerase from Sulfolobus acidocaldariusAnalysis of topoisomerase II-mediated DNA cleavage of the c-myc gene during HL60 differentiation.Analysis of DNA cleavage by reverse gyrase from Sulfolobus shibatae B12.DNA topoisomerase activities in concanavalin A-stimulated lymphocytes.Etoposide sensitivity and topoisomerase II activity in Chinese hamster V79 monolayers and small spheroids.
P2860
Q24679491-E807081D-E5B7-4A9D-9157-E4BAB90FC15DQ24685736-13F6771E-8AB6-49DC-BDDD-EF62A7EF8EE5Q28303600-793DF283-7D22-409D-9C79-7BBF39F0BD0BQ33553080-F5F49A3E-CAB0-459D-A00C-FE041F98832DQ34222480-5176A68D-BB3C-4CE3-B247-659F7D11B58BQ34684254-4384C550-D34B-4824-B4FA-05C16BD28DABQ35004917-F4BB51AD-E596-4832-A045-C5FADEDF9C48Q36002680-23BA6C2B-D868-46EB-BBB4-ECBED9C6C686Q36010020-4EA9A0C4-1802-4258-A682-315CB7E47BD6Q36191517-70A744B9-ABE1-4B44-B49F-6D39010C2CC1Q36210994-542735E0-EBBA-4352-A6B5-1F759F1E277EQ36216632-2E55A8EF-5FB5-47F8-BDB1-FFD98EBBD55CQ36224150-AE452C3E-168F-4637-BA88-C2F93F485B37Q36798224-6B5F0475-EF86-4C31-B5E5-0FEE65FFCB37Q36844631-71A38592-6F40-446C-B2D1-A48653FBE8EFQ36920787-8324E690-8C2E-4B5F-9EA7-E2B52E45CDADQ37229378-A0E62B63-C756-4B90-BC81-EC7DEF554EDEQ37400474-4505E1F6-1EBA-4938-8679-AD3337714AD9Q37687808-0F212E4B-3DDB-41B9-B8DC-C5968A5B7243Q37876263-532DB776-0FEA-48F6-BA0C-BC8C68C2A6B1Q38132645-CA611769-4974-495B-B9B8-598441DF7C29Q38321795-87B9426E-7A4A-46D7-99AC-461AE125E89DQ39820165-076DE139-D07B-40D8-BD38-8683E55B9E1DQ39851512-D62F59E6-BCD8-4A78-BD1A-1E251EE879EAQ40404953-89089F28-D9BC-4F31-A617-D61D8C2B151AQ40456249-77D0919F-08E8-4380-BAC5-550E69AEA6A4Q40553883-26F7425A-700E-49ED-88EF-935EFFBAD17BQ40800678-22420887-B9B0-4212-ABA8-38BA23381481Q40818137-EB871D58-921A-4177-BCA1-5341A64584BEQ40819671-6E646974-2115-4CE4-A1B1-ECA1B51E3775Q41410812-2EBA0B29-45E0-4CD6-B869-0B42C06E6F88Q41513713-FF8F5236-6FB9-41B8-9F3E-BB95FB214BFBQ43796668-C554AD28-CF8D-43B1-B2B8-2C28D56558A6Q46523681-FD84037B-0D52-4445-8FE9-567C4604D13FQ54290061-380252D4-0FE7-40C2-A3E0-DC8BEC746F29
P2860
DNA topoisomerases from rat liver: physiological variations.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
DNA topoisomerases from rat liver: physiological variations.
@ast
DNA topoisomerases from rat liver: physiological variations.
@en
type
label
DNA topoisomerases from rat liver: physiological variations.
@ast
DNA topoisomerases from rat liver: physiological variations.
@en
prefLabel
DNA topoisomerases from rat liver: physiological variations.
@ast
DNA topoisomerases from rat liver: physiological variations.
@en
P2093
P2860
P356
P1476
DNA topoisomerases from rat liver: physiological variations.
@en
P2093
De Recondo AM
Mirambeau G
P2860
P304
P356
10.1093/NAR/11.4.1059
P407
P577
1983-02-01T00:00:00Z